These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25666612)

  • 1. Propofol inhibits SIRT2 deacetylase through a conformation-specific, allosteric site.
    Weiser BP; Eckenhoff RG
    J Biol Chem; 2015 Mar; 290(13):8559-68. PubMed ID: 25666612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple propofol-binding sites in a γ-aminobutyric acid type A receptor (GABAAR) identified using a photoreactive propofol analog.
    Jayakar SS; Zhou X; Chiara DC; Dostalova Z; Savechenkov PY; Bruzik KS; Dailey WP; Miller KW; Eckenhoff RG; Cohen JB
    J Biol Chem; 2014 Oct; 289(40):27456-68. PubMed ID: 25086038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of propofol binding sites in a nicotinic acetylcholine receptor with a photoreactive propofol analog.
    Jayakar SS; Dailey WP; Eckenhoff RG; Cohen JB
    J Biol Chem; 2013 Mar; 288(9):6178-89. PubMed ID: 23300078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An allosteric propofol-binding site in kinesin disrupts kinesin-mediated processive movement on microtubules.
    Woll KA; Guzik-Lendrum S; Bensel BM; Bhanu NV; Dailey WP; Garcia BA; Gilbert SP; Eckenhoff RG
    J Biol Chem; 2018 Jul; 293(29):11283-11295. PubMed ID: 29844014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Diketopiperazine-Containing 2-Anilinobenzamides as Potent Sirtuin 2 (SIRT2)-Selective Inhibitors Targeting the "Selectivity Pocket", Substrate-Binding Site, and NAD
    Mellini P; Itoh Y; Elboray EE; Tsumoto H; Li Y; Suzuki M; Takahashi Y; Tojo T; Kurohara T; Miyake Y; Miura Y; Kitao Y; Kotoku M; Iida T; Suzuki T
    J Med Chem; 2019 Jun; 62(12):5844-5862. PubMed ID: 31144814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photoaffinity labeling the propofol binding site in GLIC.
    Chiara DC; Gill JF; Chen Q; Tillman T; Dailey WP; Eckenhoff RG; Xu Y; Tang P; Cohen JB
    Biochemistry; 2014 Jan; 53(1):135-42. PubMed ID: 24341978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling study for conformational changes of Sirtuin 2 due to substrate and inhibitor binding.
    Sakkiah S; Chandrasekaran M; Lee Y; Kim S; Lee KW
    J Biomol Struct Dyn; 2012; 30(3):235-54. PubMed ID: 22694102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macroscopic and macromolecular specificity of alkylphenol anesthetics for neuronal substrates.
    Weiser BP; Hall MA; Weinbren NL; Woll KA; Dailey WP; Eckenhoff MF; Eckenhoff RG
    Sci Rep; 2015 Apr; 5():9695. PubMed ID: 25853337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirtuin 2 mutations in human cancers impair its function in genome maintenance.
    Head PE; Zhang H; Bastien AJ; Koyen AE; Withers AE; Daddacha WB; Cheng X; Yu DS
    J Biol Chem; 2017 Jun; 292(24):9919-9931. PubMed ID: 28461331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Sirt2 inhibition by ligand-induced rearrangement of the active site.
    Rumpf T; Schiedel M; Karaman B; Roessler C; North BJ; Lehotzky A; Oláh J; Ladwein KI; Schmidtkunz K; Gajer M; Pannek M; Steegborn C; Sinclair DA; Gerhardt S; Ovádi J; Schutkowski M; Sippl W; Einsle O; Jung M
    Nat Commun; 2015 Feb; 6():6263. PubMed ID: 25672491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation Of Microtubule Acetylation By The Interplay Of TPPP/p25, SIRT2 And New Anticancer Agents With Anti-SIRT2 Potency.
    Szabó A; Oláh J; Szunyogh S; Lehotzky A; Szénási T; Csaplár M; Schiedel M; Lőw P; Jung M; Ovádi J
    Sci Rep; 2017 Dec; 7(1):17070. PubMed ID: 29213065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship Analysis.
    Huang S; Song C; Wang X; Zhang G; Wang Y; Jiang X; Sun Q; Huang L; Xiang R; Hu Y; Li L; Yang S
    J Chem Inf Model; 2017 Apr; 57(4):669-679. PubMed ID: 28301150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors.
    Suzuki T; Khan MN; Sawada H; Imai E; Itoh Y; Yamatsuta K; Tokuda N; Takeuchi J; Seko T; Nakagawa H; Miyata N
    J Med Chem; 2012 Jun; 55(12):5760-73. PubMed ID: 22642300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, in-vitro evaluation and molecular docking studies of novel indole derivatives as inhibitors of SIRT1 and SIRT2.
    Manjula R; Gokhale N; Unni S; Deshmukh P; Reddyrajula R; Srinivas Bharath MM; Dalimba U; Padmanabhan B
    Bioorg Chem; 2019 Nov; 92():103281. PubMed ID: 31561106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate-Dependent Modulation of SIRT2 by a Fluorescent Probe, 1-Aminoanthracene.
    Bi D; Yang J; Hong JY; Parikh P; Hinds N; Infanti J; Lin H; Weiser BP
    Biochemistry; 2020 Oct; 59(40):3869-3878. PubMed ID: 32941003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of anesthetic-induced depression of myocardial contraction.
    Meng T; Bu W; Ren X; Chen X; Yu J; Eckenhoff RG; Gao WD
    FASEB J; 2016 Aug; 30(8):2915-25. PubMed ID: 27170289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore modeling and virtual screening studies to identify novel selective SIRT2 inhibitors.
    Eren G; Bruno A; Guntekin-Ergun S; Cetin-Atalay R; Ozgencil F; Ozkan Y; Gozelle M; Kaya SG; Costantino G
    J Mol Graph Model; 2019 Jun; 89():60-73. PubMed ID: 30870650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the Mechanism of Intramolecular Inhibition of the Catalytic Activity of Sirtuin 2 (SIRT2).
    Li J; Flick F; Verheugd P; Carloni P; Lüscher B; Rossetti G
    PLoS One; 2015; 10(9):e0139095. PubMed ID: 26407304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual screening approach of sirtuin inhibitors results in two new scaffolds.
    Kokkonen P; Kokkola T; Suuronen T; Poso A; Jarho E; Lahtela-Kakkonen M
    Eur J Pharm Sci; 2015 Aug; 76():27-32. PubMed ID: 25936698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of bicyclic pyrazoles as class III histone deacetylase SIRT1 and SIRT2 inhibitors.
    Therrien E; Larouche G; Nguyen N; Rahil J; Lemieux AM; Li Z; Fournel M; Yan TP; Landry AJ; Lefebvre S; Wang JJ; MacBeth K; Heise C; Nguyen A; Besterman JM; Déziel R; Wahhab A
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2514-8. PubMed ID: 25971769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.